Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savitri Krishnamurthy

Showing results (151-160 of 262) with videos related to

Pageof 27
Sort By:
Communications Biology|January 16, 2021
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancerXiaoding Hu, Emilly S Villodre, Richard Larson, et al.
Cancer|November 11, 2006
Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factorsKatsuhiro Kobayashi, Sanjay Gupta, Jonathan C Trent, et al.
JCI Insight|February 9, 2023
Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancerKuppusamy Balamurugan, Dipak K Poria, Saadiya W Sehareen, et al.
The Oncologist|May 16, 2012
Inflammatory breast cancer: what we know and what we need to learnHideko Yamauchi, Wendy A Woodward, Vicente Valero, et al.
Breast Cancer Research : BCR|April 19, 2015
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical modelLara Lacerda, Bisrat G Debeb, Daniel Smith, et al.
Stem Cells (Dayton, Ohio)|September 11, 2012
Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signalingBisrat G Debeb, Lara Lacerda, Wei Xu, et al.
Cancer|August 19, 2004
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinomaJeannie Shen, Kelly K Hunt, Nadeem Q Mirza, et al.
Breast Cancer Research and Treatment|March 5, 2024
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysisHongxia Sun, Eun Young Kang, Hui Chen, et al.
Cancer|February 6, 2009
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancerSavitri Krishnamurthy, Funda Meric-Bernstam, Anthony Lucci, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotypeJames M Reuben, Bang-Ning Lee, Hui Gao, et al.
Pageof 27

Showing results (151-160 of 262) with videos related to

Sort By:
Pageof 27
Communications Biology|January 16, 2021
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancerXiaoding Hu, Emilly S Villodre, Richard Larson, et al.
Cancer|November 11, 2006
Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factorsKatsuhiro Kobayashi, Sanjay Gupta, Jonathan C Trent, et al.
JCI Insight|February 9, 2023
Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancerKuppusamy Balamurugan, Dipak K Poria, Saadiya W Sehareen, et al.
The Oncologist|May 16, 2012
Inflammatory breast cancer: what we know and what we need to learnHideko Yamauchi, Wendy A Woodward, Vicente Valero, et al.
Breast Cancer Research : BCR|April 19, 2015
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical modelLara Lacerda, Bisrat G Debeb, Daniel Smith, et al.
Stem Cells (Dayton, Ohio)|September 11, 2012
Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signalingBisrat G Debeb, Lara Lacerda, Wei Xu, et al.
Cancer|August 19, 2004
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinomaJeannie Shen, Kelly K Hunt, Nadeem Q Mirza, et al.
Breast Cancer Research and Treatment|March 5, 2024
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysisHongxia Sun, Eun Young Kang, Hui Chen, et al.
Cancer|February 6, 2009
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancerSavitri Krishnamurthy, Funda Meric-Bernstam, Anthony Lucci, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotypeJames M Reuben, Bang-Ning Lee, Hui Gao, et al.
Pageof 27